Form 4: Synaptics Director Buchanan Receives Equity Grant

Synaptics Inc. Director Jeffrey Buchanan was granted 3,036 shares of common stock, vesting quarterly through November 2026, aligning his interests with shareholders.

Summary

• Jeffrey Buchanan, a Director of Synaptics Inc. (SYNA), acquired 3,036 shares of common stock.
• The transaction date for this acquisition was November 3, 2025.
• The shares were acquired at a price of $0, indicating a grant of restricted stock units (RSUs).
• Following this transaction, Buchanan beneficially owns 21,657 shares of Synaptics common stock.
• The acquired restricted stock units will vest one-fourth each quarter, becoming fully vested on November 3, 2026, or earlier if Buchanan does not stand for re-election at the Issuer's 2026 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: The filing reports a standard equity grant to a director, which is generally viewed positively as it aligns the director's interests with shareholders. There are no negative implications.

Positives

• The grant of 3,036 shares of common stock to Director Jeffrey Buchanan at a $0 price aligns his financial interests directly with those of the company's shareholders.
• The vesting schedule, extending to November 3, 2026, encourages long-term commitment and performance from the director.

Negatives

• No negative aspects are directly discernible from this standard insider transaction report.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

NA

Industry Context

Equity grants to directors, often in the form of restricted stock units, are a common practice in the technology industry and publicly traded companies. This serves to align the interests of the board members with long-term shareholder value creation and retention.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard form of non-cash compensation across publicly traded companies, particularly in the technology sector.
• This practice is consistent with corporate governance best practices aimed at aligning director incentives with shareholder returns.
• For example, companies like Apple (AAPL) and Microsoft (MSFT) also utilize equity grants as a significant component of their non-employee director compensation packages, typically with multi-year vesting schedules to promote long-term commitment.

Related Party Transactions

• The grant of 3,036 restricted stock units to Director Jeffrey Buchanan constitutes a related party transaction, representing a standard form of director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's long-term interests with shareholder value creation.

Next Steps

• Vesting of 3,036 restricted stock units quarterly until fully vested on November 3, 2026.
• Potential earlier vesting if Director Buchanan does not stand for re-election at the 2026 Annual Meeting of Stockholders.

Key Dates

Keywords

Synaptics, SYNA, Form 4, insider transaction, equity grant, director compensation, restricted stock units, RSU, Jeffrey Buchanan